Update: 24.09.2024
Last week: 37 week 2024 (09.09.2024 - 15.09.2024)
Last full month: August 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 546 | 10.3% | 13.4% | 0.1 | 15 724 386 | 9.6% | 9.3% | 0.1 | 9.2% |
| MoM | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| YTD | 272 973 | 22.0% | 11.8% | 3 | 573 858 875 | 37.7% | 9.4% | 2 | -8.7% |
| MAT | 390 091 | 24.6% | 11.1% | 2.3 | 813 830 124 | 40.7% | 9.1% | 1.7 | -1.7% |
| BRAINMAX | |||||||||
| WoW | 1 585 | 6.6% | 100.0% | 0 | 5 618 515 | 5.5% | 100.0% | 0 | 6.6% |
| MoM | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| YTD | 45 601 | 58.8% | 100.0% | 0 | 161 107 572 | 64.9% | 100.0% | 0 | 58.8% |
| MAT | 63 529 | 70.0% | 100.0% | 0 | 224 393 068 | 79.1% | 100.0% | 0 | 70.0% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 092 | 2.0% | 45.2% | -1.1 | 43 465 407 | 0.5% | 37.4% | -0.9 | 4.5% |
| MoM | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| YTD | 612 928 | -5.1% | 45.0% | 0.5 | 1 927 867 853 | -2.7% | 36.8% | -2.8 | -6.2% |
| MAT | 835 957 | -0.2% | 45.3% | 0.7 | 2 638 846 210 | 4.2% | 37.6% | -2.1 | -1.7% |
| MIGRENIUM | |||||||||
| WoW | 9 657 | 5.5% | 0.4% | 0 | 3 257 607 | 6.0% | 0.5% | 0 | 7.4% |
| MoM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| YTD | 430 146 | -9.6% | 0.5% | -0.1 | 134 470 286 | 54.6% | 0.7% | 0.2 | 6.9% |
| MAT | 596 015 | -9.9% | 0.5% | -0.1 | 170 175 696 | 41.0% | 0.6% | 0.1 | 10.3% |
| MODELAX-N | |||||||||
| WoW | 25 076 | 3.7% | 20.6% | 0.4 | 11 833 938 | 3.9% | 13.5% | 0.3 | 1.7% |
| MoM | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| YTD | 1 058 773 | 31.3% | 22.5% | 3.8 | 460 692 016 | 80.7% | 14.5% | 4.1 | 9.1% |
| MAT | 1 420 326 | 45.9% | 21.3% | 4.6 | 588 543 143 | 88.9% | 13.3% | 3.9 | 14.4% |
| REDUXIN | |||||||||
| WoW | 10 091 | 7.3% | 32.4% | 0.8 | 50 757 853 | 4.2% | 43.6% | 0.5 | 4.5% |
| MoM | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| YTD | 447 465 | -8.0% | 32.9% | -0.6 | 2 383 899 977 | 12.5% | 45.6% | 3.1 | -6.2% |
| MAT | 598 847 | -5.2% | 32.5% | -1.2 | 3 137 563 310 | 15.9% | 44.7% | 2.3 | -1.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 217 | 4.2% | 10.3% | 0 | 13 699 765 | 3.8% | 11.8% | 0.1 | 4.5% |
| MoM | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| YTD | 122 121 | 0.5% | 9.0% | 0.6 | 527 194 251 | 12.6% | 10.1% | 0.7 | -6.2% |
| MAT | 166 662 | 7.6% | 9.0% | 0.8 | 712 448 439 | 19.4% | 10.2% | 0.8 | -1.7% |
| SALVISAR | |||||||||
| WoW | 11 372 | 4.9% | 1.5% | 0 | 4 852 664 | 5.0% | 1.3% | 0 | 7.1% |
| MoM | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
| YTD | 369 557 | 3.4% | 1.4% | 0.1 | 151 423 800 | 29.3% | 1.2% | 0.1 | -2.0% |
| MAT | 510 675 | -8.3% | 1.3% | -0.1 | 198 072 990 | 6.1% | 1.1% | -0.1 | 2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 272 973 | 22.0% | 11.8% | 3 | 573 858 875 | 37.7% | 9.4% | 2 | -8.7% |
| BRAINMAX | 45 601 | 58.8% | 100.0% | 0 | 161 107 572 | 64.9% | 100.0% | 0 | 58.8% |
| GOLDLINE PLUS | 612 928 | -5.1% | 45.0% | 0.5 | 1 927 867 853 | -2.7% | 36.8% | -2.8 | -6.2% |
| MIGRENIUM | 430 146 | -9.6% | 0.5% | -0.1 | 134 470 286 | 54.6% | 0.7% | 0.2 | 6.9% |
| MODELAX-N | 1 058 773 | 31.3% | 22.5% | 3.8 | 460 692 016 | 80.7% | 14.5% | 4.1 | 9.1% |
| REDUXIN CAPS | 447 465 | -8.0% | 32.9% | -0.6 | 2 383 899 977 | 12.5% | 45.6% | 3.1 | -6.2% |
| REDUXIN FORTE | 122 121 | 0.5% | 9.0% | 0.6 | 527 194 251 | 12.6% | 10.1% | 0.7 | -6.2% |
| SALVISAR | 369 557 | 3.4% | 1.4% | 0.1 | 151 423 800 | 29.3% | 1.2% | 0.1 | -2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 390 091 | 24.6% | 11.1% | 2.3 | 813 830 124 | 40.7% | 9.1% | 1.7 | -1.7% |
| BRAINMAX | 63 529 | 70.0% | 100.0% | 0 | 224 393 068 | 79.1% | 100.0% | 0 | 70.0% |
| GOLDLINE PLUS | 835 957 | -0.2% | 45.3% | 0.7 | 2 638 846 210 | 4.2% | 37.6% | -2.1 | -1.7% |
| MIGRENIUM | 596 015 | -9.9% | 0.5% | -0.1 | 170 175 696 | 41.0% | 0.6% | 0.1 | 10.3% |
| MODELAX-N | 1 420 326 | 45.9% | 21.3% | 4.6 | 588 543 143 | 88.9% | 13.3% | 3.9 | 14.4% |
| REDUXIN CAPS | 598 847 | -5.2% | 32.5% | -1.2 | 3 137 563 310 | 15.9% | 44.7% | 2.3 | -1.7% |
| REDUXIN FORTE | 166 662 | 7.6% | 9.0% | 0.8 | 712 448 439 | 19.4% | 10.2% | 0.8 | -1.7% |
| SALVISAR | 510 675 | -8.3% | 1.3% | -0.1 | 198 072 990 | 6.1% | 1.1% | -0.1 | 2.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 546 | 10.3% | 13.4% | 0.1 | 15 724 386 | 9.6% | 9.3% | 0.1 | 9.2% |
| BRAINMAX | 1 585 | 6.6% | 100.0% | 0 | 5 618 515 | 5.5% | 100.0% | 0 | 6.6% |
| GOLDLINE PLUS | 14 092 | 2.0% | 45.2% | -1.1 | 43 465 407 | 0.5% | 37.4% | -0.9 | 4.5% |
| MIGRENIUM | 9 657 | 5.5% | 0.4% | 0 | 3 257 607 | 6.0% | 0.5% | 0 | 7.4% |
| MODELAX-N | 25 076 | 3.7% | 20.6% | 0.4 | 11 833 938 | 3.9% | 13.5% | 0.3 | 1.7% |
| REDUXIN CAPS | 10 091 | 7.3% | 32.4% | 0.8 | 50 757 853 | 4.2% | 43.6% | 0.5 | 4.5% |
| REDUXIN FORTE | 3 217 | 4.2% | 10.3% | 0 | 13 699 765 | 3.8% | 11.8% | 0.1 | 4.5% |
| SALVISAR | 11 372 | 4.9% | 1.5% | 0 | 4 852 664 | 5.0% | 1.3% | 0 | 7.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| BRAINMAX | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| GOLDLINE PLUS | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| MIGRENIUM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| MODELAX-N | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| REDUXIN FORTE | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| SALVISAR | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs